giorgimassimiliano515 giu1 minDiaTheris wins first place in >>venture>> startup competitionOut of 336 initial submissions across both Business and NPO Tracks, DiaTheris is the winner of Switzerland's leading early-stage startups...
giorgioramadori27 lug 20222 minAddio insulina, presto una proteina controllerà i picchi glicemiciL'università di Ginevra lavora su una terapia alternativa basata sulla proteina S100A9, che può regolare la glicemia, i chetoni e i...
giorgioramadori27 lug 20221 minHepatic non-parenchymal S100A9-TLR4-mTORC1axis normalizes diabetic ketogenesisUnrestrained ketogenesis leads to life-threatening ketoacidosis whose incidence is high in patients with diabetes. While insulin therapy...
giorgioramadori21 lug 20221 minDiabetes: a step closer to a life without insulinA UNIGE team reveals how the S100A9 protein improves metabolism of insulin-dependent diabetics by avoiding the deleterious effects of...